Adamas Pharma (ADMS) Lower on $50M Stock Offering
Get Alerts ADMS Hot Sheet
Join SI Premium – FREE
Adamas Pharma (NASDAQ: ADMS) is lower after the company filed a prospectus covering $50 million in common stock. Shares will be offered through Cowen.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jones Ventures INTL Acquisition1 prices $200M IPO on Nasdaq
- Ernexa targets Q4 2026 for first-in-human ovarian cancer trial
- AEON Biopharma prices $13.75M public offering with milestone warrants
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share